Scinai Immunotherapeutics Ltd. American Depositary Shares (SCNI)

About SCNI

Scinai Immunotherapeutics Ltd., together with its subsidiaries, operates as a biopharmaceutical company in Israel and internationally. It engages in the research and development of IL-17 NanoAb, a VHH-based antibody platform for the treatment of immune-mediated and inflammatory diseases, including psoriasis; and PC111, a human monoclonal antibody for the treatment of pemphigus, Steven Johnson's syndrome, and toxic ep…

Sector

Health Care

Industry

Biotechnology: Biological Products (No Diagnostic Substances)

Employees

45

Website

www.scinai.com/

Fundamentals

1-day range

$2.4$2.98

Market cap

$1.37M

P/E (trailing)

0.14

P/E (forward)

—

EPS (trailing)

$-0.00

Dividend yield

—

Beta

2.16

Avg. volume

66.8K

Scinai Immunotherapeutics Ltd. American Depositary Shares Competitors

Chosen by industry and closest market cap.

• SCNI

  Scinai Immunotherapeutics Ltd. American Depositary Shares

  $2.53

  ▼ 5.60%
  Market cap $1.37MP/E 0.14
  $2.15$16.8
• VIVS

  VivoSim Labs Inc. Common Stock

  $0.29

  ▲ 0.00%
  Market cap $4.03MP/E —
  $0.2625$5.3
• PHGE

  BiomX Inc. COmmon Stock

  $0.138

  ▲ 4.55%
  Market cap $4.62MP/E —
  $0.1192$12.29
• BCAB

  BioAtla Inc. Common Stock

  $1.79

  ▼ 42.99%
  Market cap $5.41MP/E —
  $2.81$71.5
• AIM

  AIM ImmunoTech Inc. Common Stock

  $0.2558

  ▲ 2.32%
  Market cap $7.32MP/E —
  $0.1901$2.89
• BCDA

  BioCardia Inc. Common Stock

  $1.16

  ▼ 0.85%
  Market cap $9.45MP/E —
  $0.75$2.29
• CRIS

  Curis Inc. Common Stock

  $1.49

  ▲ 2.76%
  Market cap $10.04MP/E —
  $1.4$39

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• Scinai Immunotherapeutics H1 Net Income $1.6M Vs Loss $4.1M Prior Year; Revenues $949K Up From $773K YoY; Continues To Pursue ~$5M In CDMO Revenues For 2026
  benzinga · 8/24/2026

• Amir Reichman · June 16, 2026 · Grant

  400.00M
• Mark Germain · June 16, 2026 · Grant

  120.00M

Institutional Ownership

March 31, 2026

Total shares held

26.9K

Total value held

$14.9K

Institutional holders

4